Navigation Links
Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
Date:9/6/2012

SEATTLE, Sept. 6, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate clinical trials evaluating OMS824, the Company's lead compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders. OMS824 selectively inhibits PDE10, which is an enzyme expressed in areas of the brain linked to diseases that affect cognition, including schizophrenia and Huntington's disease. 

The first clinical trial evaluating OMS824 is expected to commence following the FDA's review of the IND. This Phase 1 dose-ranging study will evaluate the drug's safety, tolerability and pharmacokinetics in healthy subjects and, assuming timely clearance by the FDA, Omeros plans to begin enrollment in the fourth quarter of 2012 with data expected before year end.

"The deep and diverse pipeline behind our PharmacoSurgery™ platform has now begun to yield clinical programs," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "OMS824 represents the first new chemical entity developed wholly within Omeros that has progressed from discovery through preclinical development and is now poised to enter the clinic, underscoring our in-house capabilities to generate promising novel compounds and build them into clinical assets. Together with our Phase 1 trial results for OMS824, we also expect to announce data later this year from our two ongoing Phase 3 clinical development programs, OMS302 for ophthalmology and OMS103HP for arthroscopy."

About Omeros' PDE10 Program
PDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition, including schizophrenia and Huntington's disease. Cognitive dysfunction occurs early in these diseases and is respon
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Southfield Capital, ... firm, announced today that it completed a ... Communications. BioPharm specializes in the development and multi-channel ... pharmaceutical and biotechnology industries. Through ... shareholders half of their invested capital and ...
(Date:5/4/2015)... BOSTON , May 4, 2015 PAREXEL International ... be presenting at the UBS Healthcare Conference on Monday, May ... Senior Vice President and Chief Financial Officer will be making ... a.m. ET. A live webcast of the presentation ... at www.PAREXEL.com in the Upcoming Events portion of ...
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
Breaking Medicine Technology:Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2PAREXEL International to Present at UBS Healthcare Conference 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3
... , , SAN FRANCISCO, Aug. 21 ... first annual "Bridge to Hope," an all-day music festival set to be held ... from 11:00 a.m. to 7:00 p.m. The event will also include an ... selection of gourmet fare from a number of the city,s favorite eateries. , ...
... , , , ... Bay(R) Pharmaceuticals , Inc. (NYSE-Amex: NBY ), a ... prevention of a wide range of bacterial, viral, and fungal infections, ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA. ...
Cached Medicine Technology:Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 2Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 3Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 4Tickets On Sale Now: 'Bridge to Hope' All-Day Music Festival to Feature Top Artists, Gourmet Food, Art Show, Saturday, September 26th at Fort Mason's Great Meadow 5NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 2NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting 3
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Ticket Down ... 2015 International Champions Cup (ICC) . While the World ... and is held every four years, the International Champions Cup ... the tournament saw the all-time attendance record for soccer in ... from the Big House at the University of Michigan. This ...
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... 04, 2015 Ticket Down is a reputable ... Paul Jones Arena in Charlottesville, VA. McCartney is ... the music business and this beloved performer continues to roll ... former member of two legendary groups: Wings and The Beatles, ... business since 2013 on the “Out There” tour and has ...
(Date:5/4/2015)... 04, 2015 New findings released today ... Association (ABTA) show that people diagnosed with a brain ... options, including clinical trials, at the time of diagnosis, ... difficult decisions about their course of treatment. The release ... first nationwide brain tumor volunteer network, the ABTA CommYOUnity™, ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Pricing Healthcare ... to $3,000) of one patient receiving care at St. ... The procedure must be performed by July 15th, 2015, ... pay in full up front and forego the filing of ... more economically burdensome every year, and it devastates more and ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... (BRONX, NY) Recurrent and metastatic endometrial and ... have spread to other organs and typically have developed ... chemotherapy may not be able to endure more chemo. ... Yeshiva University have shown that a combination of two ...
... Four associations representing the state,s 114 hospitals have ... budget for 2010.Among other principles, the groups urged the ... funds and agreed on a minimum floor that all ... agreement was shared today with members of the state ...
... Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM ) ... operations. This restructuring will direct resources to business opportunities ... of proprietary compounds. With this change, the Company ... for Pharmaceutical Development & Chief Medical Officer is being ...
... acid, also in nuts, limits wrinkling , , TUESDAY, April ... are nutritious. But new research shows that a compound found ... and repair skin damage caused by the sun. , Researchers ... strawberries, cranberries and pomegranates, to human skin cells in the ...
... get worse as you get older may actually be a ... that senior citizens who think older people should perform poorly ... who do not buy in to negative stereotypes about aging ... month, psychology professor Dr. Tom Hess and a team of ...
... April 21 NBTY, Inc. (NYSE: NTY ) ( ... nutritional supplements, today announced it will web cast a conference call ... ( www.NBTY.com ), on Friday, April 24, 2009 at ... fiscal second quarter will be issued at 4:30 PM (ET) on ...
Cached Medicine News:Health News:New treatment shows promise against recurrent gynecologic cancers 2Health News:Hospital Groups Stand United on State Budget 2Health News:Hospital Groups Stand United on State Budget 3Health News:Hospital Groups Stand United on State Budget 4Health News:Immtech to Reorganize Research and Development Operations 2Health News:Immtech to Reorganize Research and Development Operations 3Health News:Compound in Berries May Lessen Sun Damage 2Health News:Think memory worsens with age? Then yours probably will 2Health News:NBTY to Web Cast Fiscal Second Quarter Conference Call 2Health News:NBTY to Web Cast Fiscal Second Quarter Conference Call 3
... procedures where stability, access, and precise, ... cantilevered low attenuation carbon fiber tabletop ... radiolucent area is free of cross ... unobstructed C-Arm positioning. Functional design provides ...
...
... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: